Cafepharma Today

September 23 2016

Valeant backlash continues, as ex-President de Silva ousted from Endo after only a few months, a device rep speaks about an acquistion gone wrong, more aftermath of the Sarepta DMD drug ruling, and more - scroll down for the latest news

Thursday's most active boards: Novo Nordisk, AstraZeneca, Sanofi,

Thursday's most active thread (Novo Nordisk): Headcount reductions being finalized

Should the government be involved in drug pricing? Come discuss on the CP group discussion board

click here for the latest message board posts
click here for the latest on pharma/biotech social media
click here for the latest on med device social media

Current News

Saluting Biotech M&A: Onward And Upward
Forbes
Saturday, September 24, 2016 - 1:42pm
tags:
biotechm M&A
3 Biotechs That Could Be M&A Targets
Motley Fool
Saturday, September 24, 2016 - 1:40pm
tags:
biotech, M&A, cancer, Seattle Genetics, Array Biopharma, Clovis Oncology
How Much Could DepoMed Fetch in a Deal?
Motley Fool
Saturday, September 24, 2016 - 1:34pm
tags:
Depomed, M&A
Sarepta quickly lays out manufacturing, launch plans after delayed approval of Duchenne MD drug
Fierce Pharma
Saturday, September 24, 2016 - 1:32pm
tags:
Sarepta Therapeutics, Kyndrisa, Duchenne Muscular Dystrophy
Generics or Specialty: Which Mylan Segment Is Growing Fastest?
Market Realist
Saturday, September 24, 2016 - 1:31pm
tags:
Mylan Labs, generics
Alexion Gets U.K. Approval for High-Cost Drug
Investopedia
Saturday, September 24, 2016 - 1:29pm
tags:
Alexion, UK, Strensiq, hypophosphatasia
Compounding an answer to drug price pain, Imprimis exec says
BioPharma Dive
Saturday, September 24, 2016 - 1:27pm
tags:
Imprimis Pharmaceuticals, drug pricing, compounded drugs, compounding pharmacies
FDA approves Amgen's copy of AbbVie arthritis drug Humira
Yahoo/Reuters
Friday, September 23, 2016 - 10:24pm
tags:
FDA, Amgen, Humira, rheumatoid arthritis, AbbVie, biosimilars
Gilead Sciences: Are Hepatitis C Sales Getting Better?
Barron's
Friday, September 23, 2016 - 10:13pm
tags:
Gilead Sciences, hepatitis C, Harvoni, Sovaldi
Is Valeant Pharmaceuticals Playing With Fire?
Motley Fool
Friday, September 23, 2016 - 10:11pm
tags:
Valeant Pharmaceuticals
Takeover Chatter Around Clovis May Be Overdone
TheStreet.com
Friday, September 23, 2016 - 10:10pm
tags:
Clovis Oncology, M&A, Eli Lilly, Merck, Takeda
Novartis's Zykadia gets positive results, faces Roche pressure
Yahoo/Reuters
Friday, September 23, 2016 - 10:07pm
tags:
Novartis, Zykadia, Roche, non-small cell lung cancer
Gilead Sciences: Another Blow to R&D Strategy
Barron's
Friday, September 23, 2016 - 10:06pm
tags:
Gilead Sciences, R&D, ulcerative colitis, GS-5745
Valeant backlash continues: De Silva out at Endo
BioPharma Dive
Friday, September 23, 2016 - 11:50am
tags:
Valeant Pharmaceuticals, Rajiv De Silva, Endo Pharmaceuticals
Novartis preps Zykadia for a frontline NSCLC pitch, but faces a tough rival in Roche; J&J, GSK hustle RA drug sirukumab to the FDA
Endpoints
Friday, September 23, 2016 - 11:47am
tags:
Novartis, Zykadia, non-small cell lung cancer, Roche, JNJ, GSK, rheumatoid arthritis, sirukumab
A Device Rep's Story of an Acquisition Gone Wrong (part 1 of 2)
CP Wire
Friday, September 23, 2016 - 11:10am
tags:
devices, device reps, sales managers, M&A
Will Gilead Make a Good Fit for Allergan?
Investopedia
Friday, September 23, 2016 - 9:56am
tags:
Gilead Sciences, Allergan, M&A
The drug industry might finally have an answer for migraines
Stat
Friday, September 23, 2016 - 9:52am
tags:
migraines, Amgen, Eli Lilly, Alder Biopharma, Teva Pharmaceutical, CGRP blockers
Big Pharma urges acquittal for ex-Acclarent execs
Mass Device
Friday, September 23, 2016 - 9:51am
tags:
Big Pharma, Acclarent, devices, Bayer, Pfizer
Where Did All That EpiPen Money Go?
Seeking Alpha
Friday, September 23, 2016 - 9:46am
tags:
EpiPens, Mylan Labs, PBMs, Heather Bresch
FDA approval in hand, Sarepta plans for future studies
BioPharma Dive
Friday, September 23, 2016 - 9:44am
tags:
FDA, Sarepta Therapeutics, Duchenne Muscular Dystrophy, Kyndrisa
AVEO Collaborates With Bristol-Myers Squibb for RCC Drug
Investopedia
Friday, September 23, 2016 - 9:43am
tags:
Aveo Pharmaceuticals, Bristol-Myers Squibb, renal cell carcinoma, tivozanib
After Sarepta win, BioMarin appeals DMD patent ruling
BioPharma Dive
Friday, September 23, 2016 - 9:35am
tags:
Sarepta Therapeutics, Biomarin, patents, Duchenne Muscular Dystrophy, eteplirsen, Kyndrisa
Secret trove reveals bold ‘crusade’ to make OxyContin a blockbuster
Stat
Thursday, September 22, 2016 - 12:20pm
tags:
oxycontin, Abbott Labs, drug reps, physicians
FDA commissioner calls for Sarepta drug study to be retracted
Stat/Pharmalot
Thursday, September 22, 2016 - 12:18pm
tags:
FDA, Sarepta Therapeutics, Robert Califf, Duchenne Muscular Dystrophy, eteplirsen
Teva, Perrigo and Sun join list of suitors checking out Bayer's $1.1B derm unit
Fierce Pharma
Thursday, September 22, 2016 - 9:46am
tags:
Teva Pharmaceutical, Perrigo, Sun Pharma, Bayer, dermatology, M&A
Expect Glaxo To Increase Consumer Focus As Walmsley Takes Driving Seat
Seeking Alpha
Thursday, September 22, 2016 - 9:39am
tags:
GSK, Pharma CEOs, Emma Walmsley, consumer health
Allergan CEO says 'the American people deserve to be angry' at price gouging
CNBC
Thursday, September 22, 2016 - 9:24am
tags:
Allergan, Brent Saunders, drug pricing
Evaluating FDA’s Approach to Cancer Clinical Trials
FDA Voice
Thursday, September 22, 2016 - 9:21am
tags:
FDA, clinical trials
Is Tesaro Another M&A Target? The Charts Say It Is
TheStreet.com
Thursday, September 22, 2016 - 9:17am
tags:
Tesaro, M&A

Latest Pharmagather Articles

Just How Worthless Are the Standard Alzheimer’s Models?
In the Pipeline
Breakthrough Therapy Status, AdComms and Approvals
eye on fda
Does Axovant Have Any Hope in Alzheimer’s?
In the Pipeline
The Chan-Zuckerberg Initiative
In the Pipeline
Drug Channels News Roundup, September 2016: Walgreens Specialty Pharmacy, CVS Caremark, Drug Spending, Theranos, and an EpiPen joke
Drug Channels
EpiPen Controversy: Mylan CEO Faces Congressional Committee
pharmexec technology
EMA Determines Certain Drugs Safe from Zika Contamination
pharmexec technology
Australian Pharma Market Set for "Modest Growth" to 2020
pharmexec technology
Better, Faster, More Comprehensive Manure Distribution
In the Pipeline

Latest CP Wire Articles

A Device Rep's Story of an Acquisition Gone Wrong (part 1 of 2)
GSK Hires First Female CEO of a Global Pharma Co - What Employees Think
One Company's Employees Say an Acquisition Was Mishandled
UroToday.com, Leading Urology Reference Site, Launches New Publication: Everyday Urology-Oncology Insights
Older Rep Seeking New Job - Advice From the Field
When Things Go Wrong With Your Job - Interview With an Employment Attorney, Part two
When Things Go Wrong With Your Job - Interview With an Employment Attorney, Part One
5 Secrets to Landing Your Dream Job
Surgeons and device reps - one rep's comments
Surgeons and Device Reps - Like Hand in Glove

CP Wire

Submit an article to cafepharma's CP Wire. Click here to find out more.

Pharma and Device News from NASDAQ

Aquinox Announces Closing of $75.4 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Friday, September 23, 2016 - 1:15pm
Achillion Announces 100% SVR12 in the 6-Week and 8-Week Cohorts in Janssen’s Phase 2 Trial Evaluating the Triple Combination Treatment Regimen Including Odalasvir, AL-335, and Simeprevir for Genotype 1 Treatment-Naïve HCV
Friday, September 23, 2016 - 11:50am
Apricus Biosciences Announces $4.6 Million Registered Direct Offering
Friday, September 23, 2016 - 8:00am
MacroGenics to Present at the Leerink Partners Rare Disease & Immuno-Oncology Roundtable
Friday, September 23, 2016 - 7:30am
NVE Awarded Grant for High Throughput Salmonella Detector
Thursday, September 22, 2016 - 4:05pm
pSivida to Present at the Ladenburg Thalmann Annual Healthcare Conference
Thursday, September 22, 2016 - 9:00am
Kiwa Announces strategic relationship with Chuon Co., LTD, of Japan
Thursday, September 22, 2016 - 9:00am
Interleukin Genetics Cites Role in Key Antisense Drug Trial Published in The Lancet
Thursday, September 22, 2016 - 8:00am
Assembly Biosciences Announces Participation in HBV Scientific Meetings in China and South Korea
Wednesday, September 21, 2016 - 7:30am
Apricus Biosciences Announces the Launch of Vitaros® in the Czech Republic and Slovakia by Recordati
Wednesday, September 21, 2016 - 7:00am

Breaking Healthcare News - powered by Seeking Alpha

Catabasis Pharma prices $10M equity offering
Friday, September 23, 2016 - 4:39pm
Thermo Fisher takes out FEI for $4.2B
Friday, September 23, 2016 - 4:30pm
FDA OKs Amgen's Humira biosimilar
Friday, September 23, 2016 - 4:21pm
FDA OKs three new uses for Novartis' Ilaris
Friday, September 23, 2016 - 4:14pm
AC Immune debuts strongly; shares up 45%
Friday, September 23, 2016 - 1:51pm
Preliminary results from mid-stage study of triple combination HCV regimen show 100% cure rate after six weeks of treatment
Friday, September 23, 2016 - 12:38pm
Novo submits application to FDA to include beefed up data in Tresiba label
Friday, September 23, 2016 - 11:36am
Healthcare - Top 5 Gainers / Losers as of 11:00 am
Friday, September 23, 2016 - 11:01am
Increase in enrollment in Marinus Pharma's mid-stage study appears to excite investors, shares up 27%
Friday, September 23, 2016 - 10:59am
Marinus soars on expansion of epilepsy trial
Friday, September 23, 2016 - 9:51am

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Latest social media